Departments of Thoracic and Cardiovascular Surgery, The Cleveland Clinic, Cleveland, Ohio, USA.
Department of Cardiothoracic Anesthesiology, The Cleveland Clinic, Cleveland, Ohio, USA.
J Card Surg. 2022 Dec;37(12):5451-5454. doi: 10.1111/jocs.17016. Epub 2022 Oct 17.
Redo cardiac surgery can present a unique set of challenges even to the experienced surgeon. Although outcomes have steadily improved in the modern era; if an intraoperative adverse event occurs, there is a 5% incidence of mortality and 19% incidence of myocardial infarction, stroke or death. Overall, the modern incidence of mortality at reoperation varies but be segregated into low and higher risk cohorts depending on the planning computed tomography imaging and risk to substernal structures on re-entry. Patients with ascending aortic or root pseudoaneurysms represent a particularly difficult subset of high-risk patients requiring reoperative cardiac surgery due to the danger of exsanguination and air embolization. The gold standard for management of such cases remains the use of deep hypothermic circulatory arrest (DHCA) to achieve safe re-entry in such cases however this can result in unpredictable DHCA duration depending on the degree of pericardial adhesions. We report a case of aortic pseudoaneurysm in a patient with patent coronary grafts managed using an endoballoon precisely positioned relative to the proximal anastomoses resulting in a safe surgical re-entry and shorter DHCA time.
再次心脏手术即使对于经验丰富的外科医生来说也可能带来一系列独特的挑战。尽管在现代时代,手术结果已经稳步改善;如果术中发生不良事件,死亡率为 5%,心肌梗死、中风或死亡的发生率为 19%。总体而言,再次手术的现代死亡率有所不同,但根据规划的计算机断层扫描成像以及重新进入时对胸骨后结构的风险,可以将其分为低风险和高风险队列。升主动脉或根部假性动脉瘤的患者由于出血和空气栓塞的危险,代表了需要再次心脏手术的高风险患者中特别困难的亚组。此类病例的黄金标准仍然是使用深低温循环停止(DHCA)来实现此类情况下的安全重新进入,但这可能导致 DHCA 持续时间不可预测,具体取决于心包粘连的程度。我们报告了一例冠状动脉移植血管通畅的患者发生主动脉假性动脉瘤的病例,使用相对于近端吻合口精确定位的内球囊进行处理,从而实现了安全的手术再次进入和更短的 DHCA 时间。